Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 166

1.

Epigenetic upregulation of HGF and c-Met drives metastasis in hepatocellular carcinoma.

Ogunwobi OO, Puszyk W, Dong HJ, Liu C.

PLoS One. 2013 May 28;8(5):e63765. doi: 10.1371/journal.pone.0063765. Print 2013.

2.

Hepatocyte growth factor upregulation promotes carcinogenesis and epithelial-mesenchymal transition in hepatocellular carcinoma via Akt and COX-2 pathways.

Ogunwobi OO, Liu C.

Clin Exp Metastasis. 2011 Dec;28(8):721-31. doi: 10.1007/s10585-011-9404-x. Epub 2011 Jul 10.

3.

Epithelial-mesenchymal transition markers expressed in circulating tumor cells in hepatocellular carcinoma patients with different stages of disease.

Li YM, Xu SC, Li J, Han KQ, Pi HF, Zheng L, Zuo GH, Huang XB, Li HY, Zhao HZ, Yu ZP, Zhou Z, Liang P.

Cell Death Dis. 2013 Oct 3;4:e831. doi: 10.1038/cddis.2013.347.

4.

MicroRNA-26a suppresses angiogenesis in human hepatocellular carcinoma by targeting hepatocyte growth factor-cMet pathway.

Yang X, Zhang XF, Lu X, Jia HL, Liang L, Dong QZ, Ye QH, Qin LX.

Hepatology. 2014 May;59(5):1874-85. doi: 10.1002/hep.26941. Epub 2014 Apr 1.

PMID:
24259426
5.

Elevated hepatocyte growth factor expression as an autocrine c-Met activation mechanism in acquired resistance to sorafenib in hepatocellular carcinoma cells.

Firtina Karagonlar Z, Koc D, Iscan E, Erdal E, Atabey N.

Cancer Sci. 2016 Apr;107(4):407-16. doi: 10.1111/cas.12891. Epub 2016 Feb 23.

6.

c-MET and HGF mRNA expression in hepatocellular carcinoma: correlation with clinicopathological features and survival.

Ang CS, Sun MY, Huitzil-Melendez DF, Chou JF, Capanu M, Jarnagin W, Fong Y, Dematteo RP, D'Angelica M, Allen P, Chen CT, O'Reilly EM, Weiser MR, Abou-Alfa GK.

Anticancer Res. 2013 Aug;33(8):3241-5.

PMID:
23898085
7.

SENP1 regulates hepatocyte growth factor-induced migration and epithelial-mesenchymal transition of hepatocellular carcinoma.

Zhang W, Sun H, Shi X, Wang H, Cui C, Xiao F, Wu C, Guo X, Wang L.

Tumour Biol. 2016 Jun;37(6):7741-8. doi: 10.1007/s13277-015-4406-y. Epub 2015 Dec 22.

PMID:
26695141
8.

u-PA and c-MET mRNA expression is co-ordinately enhanced while hepatocyte growth factor mRNA is down-regulated in human hepatocellular carcinoma.

Tavian D, De Petro G, Benetti A, Portolani N, Giulini SM, Barlati S.

Int J Cancer. 2000 Sep 1;87(5):644-9.

9.

miR-198 inhibits migration and invasion of hepatocellular carcinoma cells by targeting the HGF/c-MET pathway.

Tan S, Li R, Ding K, Lobie PE, Zhu T.

FEBS Lett. 2011 Jul 21;585(14):2229-34. doi: 10.1016/j.febslet.2011.05.042. Epub 2011 Jun 7.

10.

MACC1 suppresses cell apoptosis in hepatocellular carcinoma by targeting the HGF/c-MET/AKT pathway.

Yao Y, Dou C, Lu Z, Zheng X, Liu Q.

Cell Physiol Biochem. 2015;35(3):983-96. doi: 10.1159/000369754. Epub 2015 Feb 2.

11.

Hepatic stellate cell promoted hepatoma cell invasion via the HGF/c-Met signaling pathway regulated by p53.

Liu WT, Jing YY, Yu GF, Chen H, Han ZP, Yu DD, Fan QM, Ye F, Li R, Gao L, Zhao QD, Wu MC, Wei LX.

Cell Cycle. 2016;15(7):886-94. doi: 10.1080/15384101.2016.1152428.

12.

Cooperative interaction of MUC1 with the HGF/c-Met pathway during hepatocarcinogenesis.

Bozkaya G, Korhan P, Cokaklı M, Erdal E, Sağol O, Karademir S, Korch C, Atabey N.

Mol Cancer. 2012 Sep 11;11:64. doi: 10.1186/1476-4598-11-64.

13.

Cancer-Associated Fibroblasts Regulate Tumor-Initiating Cell Plasticity in Hepatocellular Carcinoma through c-Met/FRA1/HEY1 Signaling.

Lau EY, Lo J, Cheng BY, Ma MK, Lee JM, Ng JK, Chai S, Lin CH, Tsang SY, Ma S, Ng IO, Lee TK.

Cell Rep. 2016 May 10;15(6):1175-89. doi: 10.1016/j.celrep.2016.04.019. Epub 2016 Apr 28.

14.

Effect of hepatocyte growth factor on methionine adenosyltransferase genes and growth is cell density-dependent in HepG2 cells.

Yang H, Magilnick N, Noureddin M, Mato JM, Lu SC.

J Cell Physiol. 2007 Mar;210(3):766-73.

PMID:
17154373
15.

Heparin inhibits Hepatocyte Growth Factor induced motility and invasion of hepatocellular carcinoma cells through early growth response protein 1.

Ozen E, Gozukizil A, Erdal E, Uren A, Bottaro DP, Atabey N.

PLoS One. 2012;7(8):e42717. doi: 10.1371/journal.pone.0042717. Epub 2012 Aug 13.

16.

Extracellular signal-regulated kinase and Akt activation play a critical role in the process of hepatocyte growth factor-induced epithelial-mesenchymal transition.

Tanahashi T, Osada S, Yamada A, Kato J, Yawata K, Mori R, Imai H, Sasaki Y, Saito S, Tanaka Y, Nonaka K, Yoshida K.

Int J Oncol. 2013 Feb;42(2):556-64. doi: 10.3892/ijo.2012.1726. Epub 2012 Dec 3.

PMID:
23229794
17.

Expression of hepatocyte growth factor and its receptor c-met proto-oncogene in hepatocellular carcinoma.

Ueki T, Fujimoto J, Suzuki T, Yamamoto H, Okamoto E.

Hepatology. 1997 Apr;25(4):862-6.

PMID:
9096589
18.

Co-expression of hepatocyte growth factor and c-Met predicts peritoneal dissemination established by autocrine hepatocyte growth factor/c-Met signaling in gastric cancer.

Toiyama Y, Yasuda H, Saigusa S, Matushita K, Fujikawa H, Tanaka K, Mohri Y, Inoue Y, Goel A, Kusunoki M.

Int J Cancer. 2012 Jun 15;130(12):2912-21. doi: 10.1002/ijc.26330. Epub 2011 Sep 12.

19.

Expression of HGF, its receptor c-met, c-myc, and albumin in cirrhotic and neoplastic human liver tissue.

Ljubimova JY, Petrovic LM, Wilson SE, Geller SA, Demetriou AA.

J Histochem Cytochem. 1997 Jan;45(1):79-87.

PMID:
9010472
20.

HGF-MET signals via the MLL-ETS2 complex in hepatocellular carcinoma.

Takeda S, Liu H, Sasagawa S, Dong Y, Trainor PA, Cheng EH, Hsieh JJ.

J Clin Invest. 2013 Jul;123(7):3154-65. doi: 10.1172/JCI65566. Epub 2013 Jun 24.

Supplemental Content

Support Center